Quest Diagnostics Incorporated provides diagnostic information services worldwide. Business Operations The company is made up of two businesses, Diagnostic Information Services and Diagnostic Solutions. The company provides insights that empower and enable a range of customers, including patients, clinicians, hospitals, independent delivery networks (IDNs), health plans, employers, and accountable care organizations (ACOs). Diagnostic Information Services business This business develops and delivers diagnostic testing information and services. The value creation side of the business is organized by clinical franchise and focuses on customer solutions for the marketplace, including new test development, diagnostic insights and product marketing. The value delivery side includes sales, marketing, routine and esoteric laboratory operations, field operations, logistics, and client services. Diagnostic Solutions includes the company’s risk assessment services, diagnostic products and healthcare information technology businesses. This business provides diagnostic information services, which include providing clinical testing services, such as routine (including drugs-of-abuse) testing, gene-based and esoteric testing, and anatomic pathology services, as well as related services and insights. The company offers the access in the United States to diagnostic information services through its nationwide network of laboratories, the company-owned patient service centers, phlebotomists in physician offices. The company provides interpretive consultation through a medical and scientific staff in the industry. Services The company provides information and insights based on clinical testing, including routine, esoteric, gene-based and anatomic pathology testing, and related services. The company is focused on providing solutions and insights to its customers, based on the testing that the company performs and its extensive information and connectivity assets. The company provides routine, esoteric and gene-based and anatomic pathology testing worldwide, and offers customers the access to the most extensive test menu. The company provides infectious disease diagnostic information services and strives to be the first to provide diagnostic solutions for emerging infectious diseases, including its Focus Diagnostics offerings for West Nile Virus, SARS and Influenza A H1N1. The company has primary positions in the neurology diagnostics market, in advanced cardiovascular diagnostic information services, including its CardioIQ offering, and in cancer diagnostics, including the BRCAVantage, OncoVantage, and ColoVantage offerings. The company provides testing for the detection of employee use of drugs of abuse, offering a range of solutions, including urine, hair, blood and oral fluid tests. The company also provides biometric wellness screenings, flu shots and related preventative services that leverage clinical data to improve population health outcomes and reduce healthcare spend. The company offers biometric wellness screenings to employer populations through its patient service centers and on-site through its network of mobile examiners and nurses. In addition to a range of screening options, the company offers Blueprint for Wellness and private label reporting, analytics and incentive management services. These services are sold directly to employers and through reseller partnerships with many health plans. The company offers Quanum health information technology solutions. The company’s Quanum solutions promote its strategy, improve the value that the company provides to its customers and would result in increased customer loyalty. The company has built advanced testing capabilities, including gene-based testing services for the predisposition, diagnosis, treatment and monitoring of cancers and other diseases. The company provides integrated diagnostic information services that include both anatomic pathology and clinical pathology testing, enabling its pathologists to offer patients and clinicians a complete analysis. The company offers various esoteric tests, including but not limited to, the following f
quest diagnostics inc
(DGX:New York Consolidated)
3 Giralda Farms
Madison, NJ 07940
|Cerner Corp||$56.92 USD||-0.04|
|Hologic Inc||$34.26 USD||+0.26|
|Laboratory Corp of America Holdings||$125.33 USD||-0.53|
|Roper Technologies Inc||$176.20 USD||-1.30|
|View Industry Companies|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact QUEST DIAGNOSTICS INC, please visit www.questdiagnostics.com. Company data is provided by Capital IQ. Please use this form to report any data issues.